Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes

Minority and underresourced communities experience disproportionately high rates of fatal cancer and cardiovascular disease. The intersection of these disparities within the multidisciplinary field of cardio‐oncology is in critical need of examination, given the risk of perpetuating health inequitie...

Full description

Bibliographic Details
Main Authors: Rachel E. Ohman, Eric H. Yang, Melissa L. Abel
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.023852
_version_ 1797945380319526912
author Rachel E. Ohman
Eric H. Yang
Melissa L. Abel
author_facet Rachel E. Ohman
Eric H. Yang
Melissa L. Abel
author_sort Rachel E. Ohman
collection DOAJ
description Minority and underresourced communities experience disproportionately high rates of fatal cancer and cardiovascular disease. The intersection of these disparities within the multidisciplinary field of cardio‐oncology is in critical need of examination, given the risk of perpetuating health inequities in the growing vulnerable population of patients with cancer and cardiovascular disease. This review identifies 13 cohort studies and 2 meta‐analyses investigating disparate outcomes in treatment‐associated cardiotoxicity and situates these data within the context of oncologic disparities, preexisting cardiovascular disparities, and potential system‐level inequities. Black survivors of breast cancer have elevated risks of cardiotoxicity morbidity and mortality compared with White counterparts. Adolescent and young adult survivors of cancer with lower socioeconomic status experience worsened cardiovascular outcomes compared with those of higher socioeconomic status. Female patients treated with anthracyclines or radiation have higher risks of cardiotoxicity compared with male patients. Given the paucity of data, our understanding of these racial and ethnic, socioeconomic, and sex and gender disparities remains limited and large‐scale studies are needed for elucidation. Prioritizing this research while addressing clinical trial inclusion and access to specialist care is paramount to reducing health inequity.
first_indexed 2024-04-10T20:54:14Z
format Article
id doaj.art-1a77dd8a481142bbbe3993a1867ecacb
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-10T20:54:14Z
publishDate 2021-12-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-1a77dd8a481142bbbe3993a1867ecacb2023-01-23T07:23:59ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802021-12-01102410.1161/JAHA.121.023852Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer OutcomesRachel E. Ohman0Eric H. Yang1Melissa L. Abel2Department of Medicine University of California Los Angeles Los Angeles CAUCLA Cardio‐Oncology Program Division of Cardiology Department of Medicine University of California at Los Angeles CACenter for Cancer Research National Cancer Institute Bethesda MDMinority and underresourced communities experience disproportionately high rates of fatal cancer and cardiovascular disease. The intersection of these disparities within the multidisciplinary field of cardio‐oncology is in critical need of examination, given the risk of perpetuating health inequities in the growing vulnerable population of patients with cancer and cardiovascular disease. This review identifies 13 cohort studies and 2 meta‐analyses investigating disparate outcomes in treatment‐associated cardiotoxicity and situates these data within the context of oncologic disparities, preexisting cardiovascular disparities, and potential system‐level inequities. Black survivors of breast cancer have elevated risks of cardiotoxicity morbidity and mortality compared with White counterparts. Adolescent and young adult survivors of cancer with lower socioeconomic status experience worsened cardiovascular outcomes compared with those of higher socioeconomic status. Female patients treated with anthracyclines or radiation have higher risks of cardiotoxicity compared with male patients. Given the paucity of data, our understanding of these racial and ethnic, socioeconomic, and sex and gender disparities remains limited and large‐scale studies are needed for elucidation. Prioritizing this research while addressing clinical trial inclusion and access to specialist care is paramount to reducing health inequity.https://www.ahajournals.org/doi/10.1161/JAHA.121.023852cardiotoxicitycardio‐oncologydisparitiessocial determinants of health
spellingShingle Rachel E. Ohman
Eric H. Yang
Melissa L. Abel
Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
cardiotoxicity
cardio‐oncology
disparities
social determinants of health
title Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes
title_full Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes
title_fullStr Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes
title_full_unstemmed Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes
title_short Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes
title_sort inequity in cardio oncology identifying disparities in cardiotoxicity and links to cardiac and cancer outcomes
topic cardiotoxicity
cardio‐oncology
disparities
social determinants of health
url https://www.ahajournals.org/doi/10.1161/JAHA.121.023852
work_keys_str_mv AT racheleohman inequityincardiooncologyidentifyingdisparitiesincardiotoxicityandlinkstocardiacandcanceroutcomes
AT erichyang inequityincardiooncologyidentifyingdisparitiesincardiotoxicityandlinkstocardiacandcanceroutcomes
AT melissalabel inequityincardiooncologyidentifyingdisparitiesincardiotoxicityandlinkstocardiacandcanceroutcomes